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Quantitative proteomics and systems analysis of
cultured H9C2 cardiomyoblasts during
diﬀerentiation over time supports a ‘function
follows form’ model of diﬀerentiation†
Cynthia Kankeu,a Kylie Clarke,a Delphi Van Haver, bcd Kris Gevaert, bc
Francis Impens, bcd Anna Dittrich, e H. Llewelyn Roderick, a
Egle Passante ‡f and Heinrich J. Huber §*agh
The rat cardiomyoblast cell line H9C2 has emerged as a valuable tool for studying cardiac development,
mechanisms of disease and toxicology. We present here a rigorous proteomic analysis that monitored
the changes in protein expression during diﬀerentiation of H9C2 cells into cardiomyocyte-like cells over
time. Quantitative mass spectrometry followed by gene ontology (GO) enrichment analysis revealed that
early changes in H9C2 diﬀerentiation are related to protein pathways of cardiac muscle morphogenesis
and sphingolipid synthesis. These changes in the proteome were followed later in the diﬀerentiation
time-course by alterations in the expression of proteins involved in cation transport and beta-oxidation.
Studying the temporal profile of the H9C2 proteome during diﬀerentiation in further detail revealed
eight clusters of co-regulated proteins that can be associated with early, late, continuous and transient
up- and downregulation. Subsequent reactome pathway analysis based on these eight clusters further
corroborated and detailed the results of the GO analysis. Specifically, this analysis confirmed that
proteins related to pathways in muscle contraction are upregulated early and transiently, and proteins
relevant to extracellular matrix organization are downregulated early. In contrast, upregulation of
proteins related to cardiac metabolism occurs at later time points. Finally, independent validation of the
proteomics results by immunoblotting confirmed hereto unknown regulators of cardiac structure and
ionic metabolism. Our results are consistent with a ‘function follows form’ model of diﬀerentiation,
whereby early and transient alterations of structural proteins enable subsequent changes that are
relevant to the characteristic physiology of cardiomyocytes.
Introduction
Studying the cellular properties of cardiomyocytes and the
process of their diﬀerentiation is essential for understanding
cardiac molecular physiology and the mechanism by which the
heart acquires its function. Additionally, due to the redeploy-
ment of the foetal gene programme and physiology in disease,
studying cardiomyocyte diﬀerentiation is highly valuable to the
understanding of disease mechanisms.1 To shed light on these
questions, the rat cardiomyoblast cell line H9C2 has become a
widely used tool in cardiovascular research2 and remains of
broad interest, despite the recent emergence of other models
such as inducible pluripotent stem cells3,4 and rodent-derived
primary cardiomyocytes. The reason for the ongoing popularity
of H9C2 cells is that they have well-characterised properties in
terms of morphology and electrochemical physiology,5 can be
easily cultured over long time periods and several passages, and
enable comparison of results across labs. Moreover, for studying
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cardiac diﬀerentiation, an easy-to-use diﬀerentiation protocol
to transform H9C2 cells into a cardiomyocyte-like phenotype
(henceforth denoted as H9C2 CM) was established that involves
their maintenance in minimal serum and exposure to retinoic
acid for five days.6 Applying this diﬀerentiation protocol sub-
sequently gave rise to several studies related to cardiac develop-
ment and toxicology.7–10
Surprisingly, however, studies that validate the appropriate-
ness of H9C2 as a model for cardiomyocytes by analysing global
gene or protein expression changes during their diﬀerentiation,
and relating these changes to physiological cardiomyocyte func-
tion, are rather sparse.11–13 As one example, a recent iTRAQ-based
mass spectrometry study by Lenco and colleagues questioned the
applicability of H9C2 cells to cardiac research.13 Specifically, they
identified a lack of sufficient expression of proteins essential for
formation of striated muscle cells and muscular metabolism in
H9C2 cardiomyoblasts compared to primary cardiomyocytes.
However, their study did not consider (differentiated) H9C2 CM
cells. In contrast, Branco and colleagues most recently investi-
gated gene expression profiles in H9C2 CM cells that had been
differentiated according to the protocol described above. They
confirmed the presence of a cardiomyocyte-like phenotype by
identifying mRNAs related to cardiac muscle and mitochondrial
metabolism as being upregulated on a transcriptional level
relative to those in H9C2.14 However, their study was restricted
to investigating changes in the transcriptome, which does not
always correlate with the functional proteome;15 therefore, their
findings require support from a quantitative and systematic
proteomics analysis. This requirement is further reinforced by
the pervasive role of micro RNAs in the post-transcriptional regula-
tion of gene expression in cardiomyocytes during differentiation
and disease.16 In addition, to validate the appropriateness of H9C2
as a model for cardiomyocyte differentiation and to better under-
stand the experiments performed in these cells, a more rigorous
study is required. Such a study would investigate the interplay of
differentially regulated proteins by a systems biology approach
such as that in reference17 and by exploring the course of
differentiation over time. Here, we therefore investigate how
and in which temporal sequence H9C2 cells acquire an appro-
priate cardiomyocyte-like phenotype and physiology.
Results
H9C2 CM population demonstrates increased expression of
cardiac structural markers and a cardiomyocyte-like cell shape
The process of H9C2 diﬀerentiation was assessed in cells that were
diﬀerentiated according to the protocol described by Branco, in
which cells were cultured in medium containing low serum supple-
mented with retinoic acid over a period of five days.7 On the 6th day
of diﬀerentiation, H9C2 CM cells were considered to be diﬀeren-
tiated (H9C2 CM D6) compared to cells maintained in standard
culture medium without retinoic acid for 6 days (H9C2 D6). Using
phase contrast microscopy, we then confirmed that the shapes of
the H9C2 CM cells were elongated and partly poly-nucleated, while
the H9C2 cells had spindle-like shapes (Fig. 1A-i).
We further found that molecular markers associated with
cardiomyocyte diﬀerentiation were also increased. Specifically,
expression of myosin heavy chain (MYH) protein was increased
after diﬀerentiation (Fig. 1A-ii,18). Further, we examined cardiac
troponin I (TNNI), a key protein of the troponin complex that is
important for cardiac muscle contraction.19 Because initial
experiments using standard fluorescence microscopy suggested
the enrichment of TNNI in the perinuclear region relative to the
cytosol in H9C2 CM cells (results not shown), we investigated
its precise location using confocal microscopy. Using YOPRO
(491 nm)/TOPRO (642 nm) staining,20 we confirmed the peri-
nuclear presence of TNNI in H9C2 CM cells (green YOPRO and
red TOPRO staining for TNNI and the nucleus, respectively;
Fig. 1A-iii). Increased MYH and TNNI protein expression in
H9C2 CM cells was also confirmed on a cell population level by
immunoblotting using specific antibodies (Fig. 1B and C).
We next characterised the morphological features of H9C2
cells exposed to the diﬀerentiation protocol compared to those
under buﬀer control. We found that the H9C2 CM cells tended
toward greater lengths and smaller diameters. The length to
diameter ratios enabled us to distinguish both cell populations
at a significance level of 0.01 (t-test), while length or diameter
alone did not meet this criterion (Fig. 1D–F). We finally observed
that the duplication time of H9C2 cells was two days, in line with
previous results14 (Fig. 1G); meanwhile, after the differentiation
protocol, the rate of proliferation decreased (Fig. 1H).
In summary, application of the described diﬀerentiation
protocol resulted in changes in cell morphology and molecular
markers consistent with previously described markers of cardio-
myocyte diﬀerentiation. We therefore sought to determine whether
the entire proteome of H9C2 cells becomes more cardiomyocyte-
like following their diﬀerentiation.
Shotgun proteomics confirmed diﬀerential expression of
cardiac markers, sphingolipid metabolism and cell growth
between H9C2 and H9C2 CM
The above analysis revealed diﬀerential expression of typical
cardiac markers and altered morphology between H9C2 CM
D6 cells and H9C2 cells. To corroborate these results and to
identify functional changes between the two phenotypes, we
performed a quantitative proteomic analysis using shotgun
LC-MS/MS with data-dependent acquisition21 on three biological
replicates. In total, 2105 proteins were identified, of which 41
were found to be expressed at a statistically higher level following
diﬀerentiation (t-test with FDR = 0.01 and S0 = 1), while 28
proteins were downregulated and hence more highly expressed
in the H9C2 population (Fig. 2A and Table S1, ESI†). Proteins
that are involved in cardiac muscle contraction, such as proteins
of the troponin complex (TNNI1, TNNT2, TNNC1), myosin heavy
chain subunits (MYH1, MYH3), myosin light chain subunits and
other structural proteins (MYL4, MYL6B, MYLPF, TMP1), were
upregulated in H9C2 CM D6 cells, confirming the validity of the
diﬀerentiation protocol.
Finally, we performed gene ontology (GO) analysis using
the GOrilla gene ontology analysis tool.22 We ranked the list
of 69 proteins that exhibited statistically significant changes in
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Fig. 1 Characterisation of the H9C2 diﬀerentiation protocol revealing mixed phenotypes and length to diameter ratios. (A) Immunofluorescent
detection of cardiac markers for H9C2 D6 cells (upper panels) and for H9C2 CM D6 cells (lower panels) diﬀerentiated according to Branco7 are depicted.
Phase contrast imaging (left column (i)) reveals spindle-like shapes for H9C2 cells, while H9C2 CM cells are more elongated and partly poly-nucleated
(arrows). MYH protein was more highly expressed in the H9C2 CM population (central column (ii)). Moreover, cardiac TNNI was barely expressed in H9C2
cells, while its expression was higher in H9C2 CM cells. There, its expression was predominantly found in the perinuclear region (green area)
as demonstrated by confocal microscopy (right column (ii)). (B and C) Immunoblot analysis of MYH and cardiac TNNI confirmed their increased
expression in H9C2 CM D6. The expression levels of both proteins were normalized to actin. Data represent the mean  SD of 3 independent
experiments. A one-sided t-test was applied using a significance level of 0.05. (D–F) Morphological analysis revealed that H9C2 CM D6 cells spread to a
higher length (D) and a shorter diameter (E), leading to a significantly higher length to diameter ratio as a marker of the differentiated population (F). The
individually coloured circles indicate independent differentiation experiments and H9C2 cells, respectively. A two-sided t-test was applied using a
significance level of 0.01. (G and H) Numbers of H9C2 cells cultured on day 1 and 3 revealed a doubling time of about 48 h (G). This doubling time was
determined by enumerating live cells using a counting chamber under a phase contrast microscope and by excluding dead cells, determined by trypan
blue. Proliferation markedly slowed in H9C2 CM cells at days 4 to 7 after the end of the differentiation protocol (H).
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Fig. 2 Shotgun proteomics and gene ontology analysis revealed early changes in cardiomyocyte structure. Shotgun proteomics and subsequent gene
ontology analysis were used to compare H9C2 D0 cells with H9C2 CM D6 cells. (A) Label-free shotgun proteomics analysis revealed diﬀerential
expression of proteins associated with cardiac myocyte structure, cell proliferation and metabolism. In total, 2105 proteins were quantified and used for
t-testing to generate the volcano plot indicating the log2 (D6/D0) ratio on the X-axis and logp value on the Y-axis for each protein. 41 proteins were
significantly upregulated upon H9C2 diﬀerentiation, while 28 proteins were down-regulated (a t-test was performed with FDR = 0.01 and S0 = 1).
Components of the MYH, along with troponins and proteins involved in lipid metabolism, were upregulated in H9C2 CM cells (proteins with red marks on
the right). In turn, proteins related to cell growth, particularly those related to the helicase complex, were found to be significantly overexpressed in H9C2
(blue marks, left hand side). (B) Gene ontology analysis using GOrilla24 was performed on the gene name list from the shotgun proteomics analysis. The
list was ranked according to the strength of the relative expression in H9C2 CM cells. The results confirmed the enrichment of the GO terms that relate to
cardiac muscle diﬀerentiation and metabolism.
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expression during diﬀerentiation from the most upregulated to
the most downregulated. In this way, we found diﬀerentially
regulated functions related to cardiac muscle morphogenesis
and sphingolipid metabolism (Fig. 2B). In summary, shotgun
proteomics showed that the initial steps of cardiomyocyte
diﬀerentiation include organization of the contraction machin-
ery and the production of sphingolipids, which are essential for
mitochondrial biosynthesis.23
Fractionation-based proteome and gene ontology analysis at D8
confirmed the persistence of muscle morphology development
at early diﬀerentiation times
Motivated by the results of the shotgun proteomics analysis and to
gain insight into the cardiomyocyte diﬀerentiation of H9C2 cells,
we investigated proteome changes at other time points whilst also
aiming to increase the overall coverage of the proteome. We
therefore used a strong cation exchange SCX fractionation-based
MS approach (3 independent runs24,25) that enabled deeper pro-
teome coverage. We chose to diﬀerentiate H9C2 cells for 8 (H9C2
CM D8) and 13 days (H9C2 CM D13) to include processes that
occur at both early (H9C2 CM D8) and late (H9C2 CM D13) stages
of diﬀerentiation. The analyses of H9C2 CM D8 and H9C2 CM D6
days enabled us to gain further insight into the dynamics of early
diﬀerentiation. By fractionation, we could significantly increase the
proteome coverage. We then quantified 5143 proteins; 75 proteins
were found to be significantly upregulated and 41 were found to be
significantly downregulated at D8 of diﬀerentiation. Diﬀerential
proteome analysis confirmed increased levels of structural cardiac
muscle proteins such as troponins and myosins, together with
downregulation of glutathione peroxidase 1 (GPX1); these were also
found in H9C2 CM D6 and in H9C2 CM D8 (Fig. S1A, ESI†).
The GO analysis, as described above, suggested that changes
in GO functions relevant to cardiac muscle contraction and
morphogenesis were preserved in H9C2 CM D8 compared to
H9C2 CM D6 (Fig. S1B, ESI†), suggesting the relevance of these
mechanisms especially at earlier time points of diﬀerentiation.
Fractionation-based proteomics revealed changes in
metabolism and ionic transport at a later time point of
diﬀerentiation
We next investigated later changes of the proteome of H9C2
cells during diﬀerentiation. We therefore investigated protein
expression in H9C2 CM D13, which we compared with those in
H9C2 CM D8 and H9C2 cells maintained in standard culture
medium. Pairwise comparison of H9C2 CM D13 cells with H9C2
cells revealed 119 proteins as being significantly upregulated at
this later time point of diﬀerentiation (t-test with FDR = 0.01 and
S0 = 1), while 82 proteins were downregulated (Table S3 (ESI†),
only annotated proteins shown). In contrast, no diﬀerential
expression of proteins was observed between H9C2 CM D13 and
H9C2 CM D8 (Fig. 3A). A subsequent principal component
analysis revealed that two major principal components already
explainB60% of protein variability. These results further demon-
strated a clear clustering between biological replicates under
the same conditions, validating our diﬀerentiation protocol.
Moreover, a greater variability between replicates of H9C2 CM
D13 versus H9C2 CM D8 and H9C2 cells was observed (Fig. 3B).
While this increased heterogeneity prevented the identification
of diﬀerentially expressed proteins between D8 and D13 at the
standard significance level of this study (FDR = 0.01, S0 = 0.1),
11 upregulated and 6 downregulated proteins were revealed
when the significance criterion was relaxed (FDR = 0.05,
S0 = 0.1, Fig. S2, ESI†).
Importantly, however, despite the fact that no significant changes
between the expression of individual proteins in H9C2 CM D8 and
H9C2 CM D13 were observed using a false discovery rate of 0.01
(FDR = 0.01, S0 = 0.1), we identified gene ontology enrichment by
GOrilla. We therefore analysed a list ranked according to the
expression changes (from highly upregulated to highly down-
regulated) of all 5143 proteins found using fractionated MS.
Specifically, our results revealed highly enriched GO terms
related to cation membrane transport, cation homeostasis and
beta-oxidation at later time-points of diﬀerentiation (Fig. 3C).
Our results suggest that these metabolic and cation homeostasis-
related changes may be introduced subsequent to changes in
muscle apparatus and sphingolipid production, which we found
to be already enriched by H9C2 CM D8.
Two-way ANOVA and cluster analysis revealed eight clusters of
co-regulated proteins
The previous GO term analysis suggests a diﬀerent timing of
cardiac muscle development compared to metabolic changes
and cation homeostasis during diﬀerentiation of H9C2 cells.
Encouraged by these findings, we considered another approach
that allowed a more detailed analysis of the temporal evolution of
proteome changes during diﬀerentiation on a statistically sounder
basis. We specifically sought a method to circumvent the issue of
high inter-sample variability observed in H9C2 CM D13, which
hampered pairwise comparison of protein expression.
We reasoned that protein expression upon diﬀerentiation
evolves over time, but at diﬀerent rates in the diﬀerent cell
samples, thereby increasing variability in protein expression over
time. We surmised that by accounting for the proposed variance
in the rate of diﬀerentiation, we can correct for the original lack of
statistical significance between diﬀerentially expressed proteins.
To this end, we performed two-way ANOVA on the intensities of all
5143 identified proteins in the diﬀerentiated group (D0 vs. pooled
D8 and D13) and the diﬀerentiation time group (D0 vs.D8 vs.D13;
Fig. 4A). We found 843 proteins to be significantly diﬀerentially
expressed ( po 0.05). These proteins included some that showed
significant expression changes either in the diﬀerentiation group
(N = 748) or the diﬀerentiation time group (N = 650, wherein
N = 547 proteins were common). These proteins were further
subjected to hierarchical clustering. Through this analysis, we
identified eight unique clusters describing co-regulated proteins
that were up- or downregulated either early, late, continuously, or
transiently upon diﬀerentiation (Fig. 4B).
Reactome analysis of proteins from diﬀerent clusters identified
pathways related to diﬀerent temporal regulation dynamics
Having identified that the proteins that were statistically
significantly diﬀerentially expressed upon diﬀerentiation and
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Fig. 3 Fractionation-based shotgun proteomics and gene ontology analysis for early versus late diﬀerentiated H9C2 CM cells. (A) The volcano plot
comparing early diﬀerentiated H9C2 CM (H9C2 CM D8) and late diﬀerentiated H9C2 CM (H9C2 CM D13) cells indicates that no single protein was found
to be diﬀerentially regulated with a p value of significance of 0.01. This is likely due to the higher variability of protein expression in the H9C2 CM D13
replicates (as demonstrated in panel B). (B) Principal component analysis was performed on all quantified proteins. Three biological replicates were
performed for each condition, comprising H9C2 D0, H9C2 CM D8 and H9C2 CM D13. (C) Explorative gene ontology enrichment analysis employing
GOrilla and using the list of proteins from the fractionation-based mass spectrometry analysis of H9C2 CM D13 vs. H9C2 CM D8. Proteins were ranked
according to their relative expression at late versus early diﬀerentiation times in descending order; a rat gene background was used in GOrilla. GO
functions associated with cation homeostasis, cation membrane transport and beta-oxidation were enriched, suggesting that changes in fatty acid
metabolism and cardiac ion electrophysiology occur temporally after structural changes have occurred, as shown in Fig. 2B.
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according to time of diﬀerentiation segregated into 8 clusters
based upon their pattern of expression, we analysed the path-
ways that are associated with these clusters. We subjected the
proteins of each cluster to the Reactome pathway analysis
tool.26 This allowed us to link the temporal regulation pattern
to biological function. The results are shown in Fig. 5 and Fig. S3
(ESI†), wherein clusters from Fig. 4 were rearranged to emphasize
the aspects of early vs. long-term and between transient vs.
continuous protein regulation. We depicted graphs of the most
diﬀerentially regulated pathways identified by Reactome. We
therefore ranked the identified pathways according to their
percentile enrichment, which we defined by the number of
proteins from the cluster that were associated with the pathway
divided by the total number of proteins related to that pathway by
Reactome (both numbers are shown above each bar).
The cluster comprising early upregulated proteins (C4) was
enriched for pathways related to striated muscle and generic
muscle contraction (Fig. 5A). In turn, the cluster of early down-
regulated proteins (C8) was enriched for proteins involved in elastic
fiber formation and extracellular matrix (ECM) organization.
Together, these results are consistent with the notion that the
establishment of cardiomyocyte structure is the hallmark of early
diﬀerentiation.
In turn, and consistent with our previous GO analysis, we
found that proteins that were upregulated at later time points
of diﬀerentiation (C13) were mainly associated with metabolic
pathways (glucose, carbohydrates, fatty acid/beta-oxidation;
Fig. 5B, black bars), while proteins that were downregulated
at later time points were not significantly enriched for any
pathway (Fig. 5B, grey bars). Therefore, the higher pathway
enrichment for continuously and late-upregulated proteins
compared to those associated with downregulation suggests
that long term changes in cell phenotype during diﬀerentiation
are governed by acquisition of new functions rather than by
suppression of existing functions.
As a nuance, we also found proteins involved in metabolic
pathways that were enriched within the cluster of continuously
upregulated proteins, indicating that the activation of some meta-
bolic functions may have already started at early time points of
diﬀerentiation (Fig. 5C, black bars). Moreover, mRNA splicing and
pre-processing were found to be enriched within the cluster of
continuously downregulated proteins (Fig. 5C, black bars). Finally,
while enrichment of pathways within the cluster of transiently
upregulated proteins was low, we found that pathways related to
cell cycle progression and gene expression were associated with the
cluster of proteins that were only transiently downregulated. This
relatively high proportion of transiently downregulated proteins
related to replication in cardiomyocytes may suggest that once
proliferation decreases, further changes towards a non-
proliferation phenotype are no longer required (Fig. 5D).
Finally, we note that unlike the above GOrilla analysis, Reactome
analysis did not reveal information on alterations of ion channels
and homeostasis during diﬀerentiation. However, manual screening
of the cluster results revealed some ion transport-related proteins
in the cluster of continuously upregulated proteins (5 transporter
proteins of 10 from all clusters; Data S1, ESI†).
Biochemical validation of selected proteins related to
cardiomyocyte structure and metabolism
We finally confirmed our proteomics data by immunoblot
analysis. We specifically focused on proteins that are involved
in cardiac structure and metabolism, which were identified to
Fig. 4 Two-way ANOVA and hierarchical clustering identified sets of statistically significant and co-regulated proteins. (A) To obtain a statistically
interpretable pattern of how diﬀerentiation time influences diﬀerentiation status, two-way ANOVA was performed. We therefore pooled all 5143
identified proteins from H9C2 CM cells (D8 and D13), compared the resulting pool to proteins identified in H9C2 (D0), and analysed their expression vis-
a`-vis the diﬀerentiation times (D13 vs. D8 vs. D0). 843 proteins were identified that showed significant expression changes either in the diﬀerentiation
group or in the diﬀerentiation time group. (B) These proteins were further subjected to unsupervised hierarchical clustering, which revealed eight clusters
of co-regulated proteins over time. These eight clusters were defined by proteins that exhibited early, late, continuous and transient upregulation and
downregulation of expression following diﬀerentiation.
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have high expression values and high significance at least at one
time point of diﬀerentiation (early or late). Having initially vali-
dated TNNI and MYH to be elevated in H9C2 CM (see Fig. 1), we
did not further examine the high expression of troponin and
myosin subunits that were identified in our proteomics datasets.
For four other proteins, selected according to the criteria outlined
above, we were able to source antibodies that robustly detected
them and exhibited suﬃcient reproducibility with acceptable inter-
experimental variability. For each of those proteins, we compared
H9C2 CM D8 and H9C2 CM D13 cells with H9C2 cells that were
cultured in parallel (Fig. 6).
First, we quantified ACSL3 (long-chain-fatty-acid–CoA ligase 3),
a protein that is involved in lipid biosynthesis and fatty acid
degradation.27 From our proteomics analysis (Table 1), ACSL3 was
present in cluster 3 of persistently upregulated proteins, with
upregulation in H9C2 CM D8 at lower significance (FDR = 0.05)
and in H9C2 CM D13 at higher significance (FDR = 0.01). Indeed,
immunoblotting confirmed this significant increase at both time
points compared to control cells.
We next focused on Caveolin-3 (CAV-3), a major building
block of caveolae, which are specialized microdomains in the
sarcolemma membranes of ventricular myocytes involved in
Fig. 5 Reactome pathway analysis of proteins associated to each cluster. Proteins associated with each cluster of Fig. 4 were linked to signalling
pathways using the tool Reactome. Clusters were re-arranged for practical reasons. The output of Reactome was excerpted, and pathways were ranked
according to their enrichment. This enrichment, defined by the number of proteins found in the cluster versus the total amount of proteins in the
respective pathway, is depicted by the numbers above each bar. Black and grey bars show analyses for clusters with up- or downregulation, respectively,
for (A) early, (B) late, (C) continuous and (D) transient regulation. Only pathways containing at least 2% of all proteins of the cluster (* 1% for late-
downregulated proteins) were considered. We noted that proteins related to muscle contraction were regulated rather early, while those related to
metabolism were regulated rather late. In turn, proteins contributing to extracellular matrix (ECM) organisation were downregulated early, while those
relevant to the cell cycle showed transient downregulation. Further details are given in the text.
Research Article Molecular Omics
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
7 
M
ay
 2
01
8.
 D
ow
nl
oa
de
d 
on
 6
/2
5/
20
18
 2
:0
7:
04
 P
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
This journal is©The Royal Society of Chemistry 2018 Mol. Omics, 2018, 14, 181--196 | 189
Fig. 6 Immunoblot analysis of diﬀerentially expressed proteins. H9C2 CM D8, H9C2 CM D13 (+) and H9C2 cells () were maintained in their respective media
before performing the analysis. Our proteins of interest were quantified in those cells by western blot. For normalisation of sample loading, total proteins were
detected on the blot by a reversible total protein stain (lanes at left to each bar graph). The relative abundance of the proteins of interest between the test and
control samples (H9C2 cells cultivated at the same time points D8 or D13, respectively) were then determined by normalising to the total protein. This approach
aimed to minimise diﬀerentiation state eﬀects. A significant upregulation (*po 0.05, ***po 0.01, one-sample t-test of log-transformed data with a hypothetical
value of 0) for most proteins and time points was observed, and the results were compared to the proteomics in the Results section. The images are representative
of 6 diﬀerent experimental studies. (A) ACSL3, (B) CAV-3, (C) CA1, (D) SGCD with left and right panels depicting diﬀerentiation at D8 and D13, respectively.
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regulation of cardiac signalling and function. CAV-3 contributes
to the formation of these microdomains through association with
several cardiac ion channels and signalling proteins.28 Consistent
with our proteomics results, immunoblotting analysis identified
significant upregulation of CAV-3 in H9C2 CM D8 and H9C2 CM
D13 (Fig. 6B).
We then investigated carbonic anhydrase isoform I (CAI), a
metabolic enzyme that is usually found in red blood cells and
the gastrointestinal tract29 but, surprisingly, was identified as
the fourth most significantly upregulated protein in H9C2 CM
D13 vs. H9C2 cells and was also identified as being upregulated in
H9C2 CM D8 (Tables S2 and S3, ESI†). Indeed, immunoblotting
analysis confirmed significant upregulation at both time points
(Fig. 6C). These results indicate that this enzymemay have a yet-to-
be-determined role in cardiomyocyte diﬀerentiation or function.
We finally investigated the structural protein d-sarcoglycan
(SGCD), a member of the sarcoglycan family, which are single-
pass transmembrane proteins localized at the sarcolemmas
of muscle fibers.30 Here, immunoblot analysis confirmed a
statistically significant upregulation in H9C2 CM D8, as identi-
fied by our proteomics data. In contrast, no altered expression
in H9C2 CM D13 was identified, which is contrary to the
proteomics results but consistent with the association of this
protein with the transiently regulated cluster as identified by
our cluster analysis.
Discussion
Cellular diﬀerentiation involves transformations in the size,
morphology, metabolic activity and signal transduction of a cell
to acquire the characteristics of its mature phenotype.31 These
cellular properties are ultimately determined by changes in the
functional proteome. We therefore analyzed the temporal changes
of the proteome of H9C2 cells during diﬀerentiation to provide a
compendium for this frequently used cellular system to study
cardiomyocyte biochemistry. Using two independent analytical
approaches, our results support a ‘function follows form’ model,
whereby initial changes in the proteome provide the basic
morphology and contraction apparatus for later development
of functions that establish cardiac physiology.
First, gene ontology analysis using the GOrilla tool provided
us with an overview of the biological functions that are
enriched during early and late stages of H9C2 diﬀerentiation.
This analysis extracts statistically relevant relationships that are
included in the interrelation between the identified proteins
and their expression, even if some of the proteins are not
statistically regulated by themselves. Our results suggested that
at earlier times of diﬀerentiation, H9C2 CM cells upregulate
cardiac structural proteins (such as troponins and myosins)
and initiate pathways involved in sphingolipid catalysis and
synthesis. Sphingolipids are building blocks of the mitochondrial
membranes, where they exert various structural and function-
related tasks.23,32 Hence, their production can be seen as a proxy
for the generation of mitochondria at early time points. Our
results therefore suggest that by producing mitochondria,
cardiomyocyte diﬀerentiation lays the foundation for enabling
beta-oxidation of fatty acids, which indeed was detected at later
stages of diﬀerentiation by our GO analysis. This reasoning
is supported by the observation that mitochondrial mass
increases during H9C2 cell diﬀerentiation33 and that increased
mitochondrial mass is a prerequisite to address the high energy
need of H9C2 CM cells.34 Similarly, elevation of cardiac-specific
ion transporters was suggested to occur at later time points.
Elevation of these transporters as a consequence of H9C2 cell
diﬀerentiation has been previously reported; however, the con-
crete timing of their elevation was not investigated in detail.3
As a second approach, we combined two-way ANOVA with a
hierarchical cluster analysis. By this approach, we relaxed the
stringency for eﬀect detection (while retaining it within accepted
limits), which was necessary to account for the detected increase
in intra-sample heterogeneity with duration of diﬀerentiation.
Table 1 Summary of proteomic data for proteins selected for validation at the measured time points. An outline of the proteomics results for the
proteins validated by immunoblotting is given. The levels of statistical significance, levels of diﬀerential expression, gene symbols and full protein names
are given, along with the involvement of the proteins in structural or metabolic functions and their false discovery rates (FDR). Detailed lists can be found
in ESI Tables S1–S3
log(p-value) log2 diﬀ/undiﬀ Gene symbol Protein name Function Significance
D8 vs. D0
3.15 1.14 ACSL3 Long-chain-fatty-acid–CoA ligase 3 Metabolic FDR: 0.05
1.64 3.09 CAV-3 Caveolin-3 Structure FDR: 0.01
1.84 1.76 CA1 Carbonic anhydrase 1 Metabolic FDR: 0.05
2.54 2.75 SGCD d-Sarcoglycan Structure FDR: 0.01
D13 vs. D0
4.05 2.17 ACSL3 Long-chain-fatty-acid–CoA ligase 3 Metabolic FDR: 0.01
1.60 3.31 CAV-3 Caveolin-3 Structure FDR: 0.01
3.31 4.49 CA1 Carbonic anhydrase 1 Metabolic FDR: 0.01
2.11 3.19 SGCD d-Sarcoglycan Structure FDR: 0.01
D13 vs. D8
3.54 1.03 ACSL3 Long-chain-fatty-acid–CoA ligase 3 Metabolic FDR: 0.05
0.16 0.22 CAV-3 Caveolin-3 Structure No sig.
3.90 2.73 CA1 Carbonic anhydrase 1 Metabolic FDR: 0.05
0.25 0.44 SGCD d-Sarcoglycan Structure No sig.
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Indeed, this observed heterogeneity is consistent with studies in
human embryonic stem cell lines, suggesting that genetic diﬀer-
ences progressively amplify during cardiac diﬀerentiation.35,36
Our two-way ANOVA approach enabled us to identify proteins
that are diﬀerentially regulated with respect to diﬀerentiation
status and timing while identifying eight clusters of co-regulated
proteins. Proteins associated with each cluster were then sub-
jected to Reactome pathway analysis, which gave information for
each of the clusters on the pathways involved during diﬀerentia-
tion at diﬀerent time points. While the results of both approaches
partly overlap, comparison of the two approaches may suﬀer from
the occasionally inconsistent nomenclature of pathway and func-
tion terms used by GOrilla and Reactome. Indeed, while the GO
analysis revealed regulation of ion transporter processes between
H9C2 CM D8 and H9C2 CM D13, Reactome analysis did not
prominently highlight these changes. One explanation for this
discrepancy is a failure of the Reactome analysis to perform
appropriate pathway categorization. More likely, however, the
cluster analysis did not detect statistical significance on an
individual gene level due to the greater sample variability in
H9C2 CM D13 compared to H9C2 CM D8. In contrast, our GO
analysis, which shifts away from an individual gene-oriented view
to a gene group-based analysis, seems to be more suitable
in situations where the individual sample variation is high.37
However, we note that the results of both analyses were clearly
consistent with respect to the fact that the development of cardiac
muscle morphology preceded changes in metabolism.
The results of our study are consistent with a recent gene
expression profiling study of H9C2 cell diﬀerentiation by
Branco et al.14 in which H9C2 cells were diﬀerentiated accord-
ing to the same protocol used here. Branco and colleagues
showed upregulation of mRNAs that encode structural cardiac
and metabolic proteins in H9C2 CM cells. Our study adds to
this by confirming that these processes are also translated at
the protein level and by explaining how the gain of cardiomyo-
cyte function evolves over time. Consistent with the study of
Branco and colleagues, we found that lactate dehydrogenase
subunit B (LDHB) is significantly upregulated and glutathione
peroxidase 1 (GPX1) is significantly downregulated at both early
and late diﬀerentiation time points. The increased expression of
LDHB may enable increased conversion of lactate to pyruvate,
hence indicating altered pyruvate/lactate metabolism in response
to diﬀerentiation.38 In contrast to this, the consequences of the
decreased expression of GPX1 in H9C2 CM cells may be more
subtle. As GPX1 is often regarded as a harbinger of oxidative
stress,39 decreased GPX1 in H9C2 CM cells may be an indicator of
decreased anti-oxidant potential; thus, H9C2 CM cells, and poten-
tially also mature primary cardiomyocytes, may be more suscep-
tible to oxidative stress.40 However, we remark that it was not
possible to validate the protein regulations of LDHB and GPX1
found in our proteomics analysis by immunoblotting due to the
lack of antibody specificity and high variability of the respective
antibody signals between replicates (similar to the study by
Branco et al.14 in the case of LDHB, results not shown).
Despite the restriction of sourcing appropriate rat anti-
bodies for interesting but nonstandard proteins, we provided
several independent validations of structural and potential
functional proteins relevant to cardiomyocyte function. Thus,
in addition to the validation of the classical cardiac markers
TNNI and MYH, we also investigated ACSL3, CAV-3, CA1 and
SGCD. As such, the metabolic enzyme ACSL3 was found to be
persistently upregulated in the proteomics study and immuno-
blot validation; it most likely addresses the high energy need in
more mature cardiomyocytes. In turn, due to its involvement in
lipid synthesis,27 ACSL3 may govern important cardiomyocyte-
relevant anabolic processes such as de novo production of
mitochondria. To this end, sphingolipid production was already
identified as a major function in our gene ontology analysis at
earlier time points. Similarly, the proteomics results showing
upregulation of the structural proteins SGCD and CAV-3 were
previously confirmed at early time points. It has been shown that
both proteins are essential for maintaining cardiac structure and
that their expression attenuates cardiac dystrophy.41,42 Moreover,
CAV-3 has been shown to associate with several cardiomyocyte-
membrane ion channels and to be involved in key cardiomyocyte
and muscle-specific functions.43 Finally, we also identified CA1,
an enzyme that catalyses the rapid interconversion of carbon
dioxide and water to bicarbonate and protons (or vice versa), as
being highly significantly upregulated, particularly at later time
points of diﬀerentiation. In addition to CA1, which is key to
proton production, other CA isoforms have also been found to be
associated with proton exchanger channels and their functions;44
this suggests that CA1 plays a role in cardiac pH regulation. As
tight pH regulation is essential for appropriate function of cardiac
myofilaments,45 it is therefore tempting to speculate that CA1 has
a yet undiscovered role in mediating cardiac contraction or during
its malignant deregulation.
We further identified TNNI, one of the three canonical
troponin isoforms, as a marker that distinguishes cardiomyo-
cytes from other muscle cells. Interestingly, confocal micro-
scopy suggested that cardiac TNNI was not evenly distributed in
the cytoplasm but enriched in the perinuclear area. Consistent
with our results, Franklin et al.46 employed mass spectrometry
to demonstrate that troponins are present in the nuclei
of neonatal rat ventricular cardiomyocytes. Our data further
support previous findings of Bergmann et al.47 that suggest a
perinuclear location of TNNI.48 While the exact function of
perinuclear TNNI is elusive, a potential role of perinuclear
cardiac troponins in cell senescence and, hence, in age-related
diseases has been proposed.49
Our study has some limitations. First, we did not focus on
phosphoproteomics changes. However, while phosphorylation
events contribute to signalling, such as the induction of diﬀer-
entiation, these phosphorylation events are generally transient
in nature and, with decreasing initial stimulus, would likely
be undetected even at day 6. Indeed, an initial shotgun phos-
phoproteomics approach at day 6 of diﬀerentiation was vastly
unsuccessful in detecting alterations in the phosphorylation of
enzymes related to cardiomyocyte structure or metabolism
(results not shown). This view of the lack of influence on
phosphorylation at the investigated time point is supported by
a recent study by one of our co-authors (LHR). They examined
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the temporal profile of ERK phosphorylation and immediate
gene activation during hypertrophic remodelling in neonatal
myocytes and found them be transient, subsiding after 15 to
30 min.50 Similar results have been observed for many other
signalling pathways in cardiac hypertrophic remodelling.51 In
addition, despite increasing proteome coverage using a fractiona-
tion approach, leading to the identification of over 5000 proteins
in H9C2 cells, low-abundant proteins such as those related to
signal transduction are more diﬃcult to detect compared to those
related to morphology or metabolism. As such, these proteins
require substantial enrichment for detection.52 This leads to an
unavoidable bias toward highly expressed proteins, which is
inherent in every current proteomics approach. However, we
conclude that proteomic coverage enables the detection and
analysis of changes in proteins that govern cardiomycyte structure,
function and metabolism. In summary, we confirmed that the
applied diﬀerentiation protocol drives H9C2 cells towards a
cardiac muscle phenotype; moreover, we suggested a temporal
diﬀerentiation sequence that first establishes the necessary
morphology for subsequent metabolic changes.
Methods
Cell culture
H9C2 cells (Sigma, Leuven, Belgium) were cultured in Dulbecco’s
Modified Eagle’s Medium (DMEM) supplemented with 10% fetal
bovine serum (FBS), 2 mM glutamine, 100 U per ml penicillin
and 100 mg per ml streptomycin in humidified air (CO2 5%) at
37 1C. The culture medium was changed every 2 days, and the
cells were split upon reaching around 80% confluence to avoid
loss of diﬀerentiation potential. To diﬀerentiate H9C2 cells, they
were cultured 5 days in DMEM supplemented with 1% FBS and
1 mM of trans-retinoic acid (ATRA). ATRA was dissolved in
DMSO, and the aliquots were stored at 20 1C in the dark to
prevent loss of activity.
After passaging, H9C2 cells were allowed to adhere over-
night in DMEM supplemented with 10% FBS in 75 cm2 flasks at
a density of 4666 cells per cm2 for diﬀerentiation conditions or
666 cells per cm2 for control conditions. Addition of ATRA to
the medium was performed daily for 5 days. After the 5th day,
H9C2 CM cells were maintained in culture in 1% FBS-containing
medium for 1, 3 or 8 additional days without ATRA. Those cells
were respectively denoted as H9C2 CM D6, H9C2 CM D8 and
H9C2 CM D13. H9C2 cells were also maintained in culture for 1,
6, 8 or 13 days and were respectively named H9C2 D0, H9C2 D6,
H9C2 D8 and H9C2 D13.
Proliferation assay
To determine the doubling times of H9C2 and H9C2 CM, cells
were counted after 1, 2, 4 and 7 days in culture. To this end,
the supernatant of the cells was collected in a falcon tube.
Subsequently, the cells were washed with PBS, trypsinised and
combined with the cells from the supernatant. The cells were
then centrifuged at 0.2 rcf for 5 min and the supernatant was
discarded. The cells were resuspended in PBS and stained with
trypan blue to exclude dead cells. Cell proliferation was deter-
mined by counting living cells using a counting chamber under a
phase contrast microscope (Axiovert 200M inverted microscope,
Carl Zeiss NV, Jena, Germany) and by excluding dead cells.
Immunoblotting and densitometry
Cellular lysates were prepared from cells harvested from the
media and combined with the trypsinised adherent cells, then
washed in PBS and re-suspended in lysis buﬀer (50 mM Tris
HCl, pH 7.6; 150 mM NaCl; 0.1% SDS; 0.1% deoxycholate; 1%
Triton X100; 1 mM sodium orthovanadate; 1 mM sodium fluoride)
for 30 min at 4 1C. Cells were centrifuged at 15700 rcf for 10 min.
The protein concentration of samples was determined by
the BCA assay (Thermo Fisher Scientific, Ghent, Belgium).
Following denaturation at 90 1C for 5 min in Laemmli sample
buﬀer, equivalent amounts of protein (25 mg) were separated by
electrophoresis in 8%, 10% or 12% SDS–polyacrylamide gels
(SDS–PAGE). The resolved proteins were then transferred to
nitrocellulose membranes (0.2 m pore size, Amersham GE
Healthcare, Brussels, Belgium). The membranes were blocked
in 5% milk/PBS for 1 h at room temperature and incubated
overnight at 4 1C with antibodies directed against MYH (1:1000,
Abcam, Cambridge, UK, ab185967) and TNNI (1:1000, Abcam,
Cambridge, UK, ab56357). After washing the membranes
3 times with TBST (50 mM Tris–HCl, pH 8; 100 mM NaCl and
0.1% Tween 20), they were further incubated with horseradish
peroxidase (HRP) conjugated secondary antibodies, goat anti-
mouse IgG (1:10.000, Abcam, Cambridge, UK, ab6789) and goat
anti-rabbit (1:10.000, Abcam, Cambridge, UK, ab6721) for 1 h at
room temperature. Immunoreactive bands were detected by
enhanced chemiluminescence (Amersham GE Healthcare,
Brussels Belgium). Expression of proteins was determined by
densitometry of the bands using Image Lab software (Bio-Rad,
Temse, Belgium).
For validation of ACSL3, CAV-3, CA1 and SGCD, protein
expression was determined by fluorescence imaging of immuno-
reactive bands. To normalize for protein expression between
samples, total proteins on the blot were stained using the
LICOR REVERT (Leusden, Netherlands) total protein stain kit
prior to immunodetection of proteins of interest according to
the manufacturer’s instructions. After removal of this stain,
the membranes were blocked in 5% milk/PBS for 1 h at
room temperature and then incubated overnight at 4 1C with
antibodies directed against CAV-3 (1:1000, BD Transduction,
Erembodegem, Belgium, 610420), CA I (1:5000, Abcam, Cambridge,
UK, ab108367), SGCD (1:1000, Cambridge, UK, orb247720), and
ACSL3 (1:1000, Abcam, Cambridge, UK, ab151959). After washing
the membranes 3 times with TBST (50 mM Tris–HCl, pH 8;
100 mM NaCl and 0.1% Tween 20), they were further incubated
with fluorescently-conjugated secondary antibodies: donkey
anti-mouse IgG 800 (1:10 000, LICOR, Leusden, Netherlands,
925-32210) and Alexa fluor donkey anti-rabbit IgG 680
(1:10.000, Invitrogen, Merelbeke, Belgium, A10043) for 1 h at
room temperature. The membranes were washed 3 times with
TBST (50 mM Tris–HCl, pH 8; 100 mM NaCl and 0.1% Tween
20) and once with TBS (50 mM Tris–HCl, pH 8; 100 mM).
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The bands were visualized using a LICOR – Odyssey CLX
imaging system, and densitometry was performed using Image
Studio software (LICOR, Leusden, Netherlands). The expression
levels of proteins were first normalized to the total protein stain
and then normalized to H9C2 cells of the same passage and at
the same time of culturing (D8 and D13). After logarithmic
transformation of the data, a one sample t-test with a hypothe-
tical value of 0 was used to establish statistical significance at a
p-value o 0.05, unless indicated otherwise.
Immunocytochemistry
H9C2 CM and H9C2 cells were seeded on coverslips in 6-well
plates at numbers of 1066 and 1600 cells per cm2. After over-
night incubation, the cells were washed with PBS and fixed
in PFA for 20 min. The fixed cells were washed once with PBS
and permeabilized with 0.1% Triton X-100 for 15 min. The
permeabilized cells were washed 3 times with PBS/0.5% BSA.
The cells were blocked for 1 h with PBS/0.5% BSA, then incubated
separately with primary antibodies against mouse anti-cardiac
MYH (1:1000, Abcam Cambridge, UK, ab185967) or rabbit anti-
cardiac TNNI (1:1000, Abcam, Cambridge, UK, ab56357) 1 : 50 in
blocking solution overnight at 4 1C. The cells were washed 3 times
for 5 min with TBST. Subsequently, secondary antibodies were
added (anti-mouse Alexa Fluor 647, ab150127 and anti-rabbit
Alexa Fluor 488, ab150077, 1 : 100 in blocking solution, Sigma,
Leuven, Belgium) for 2 h at room temperature. The coverslips
were mounted on glass slides using ProLong anti-fade reagent
(Life Technologies, Brussels, Belgium). Cells stained with anti-
bodies against MYH were observed by fluorescence microscopy
using a Zeiss microscope with appropriate filter sets (Axiovert
200M invertedmicroscope, Carl Zeiss NV, Jena, Germany), and cells
stained with antibodies against TNNI were observed on the Zeiss
LSM 700 confocal microscope using a 60 1.3 NA oil immersion
objective. Images of cells stained with anti-MYH and anti-TNNI
antibodies were obtained using Axio vision software and ZEN 2012
software, respectively (Carl Zeiss NV, Jena, Germany).
Proteomics sample preparation
To extract proteins for proteomics analysis, cells were washed
twice with PBS and scrapped in lysis buﬀer (8 M urea; pH 8.0,
20 mMHEPES; 2 phosphor-stop tablets, Sigma, Leuven Belgium).
The cells were then sonicated 3 times for 15 s each and centrifuged
at 16000 rcf for 15 min. The protein concentrations of the samples
were determined by the BCA assay according to the manufacturer’s
instructions (Thermo Fisher Scientific, Ghent, Belgium). Proteins
(2 mg) were frozen at 20 1C prior to digestion.
Proteomics samples were prepared in triplicate for each
condition. From each replicate, equal protein amounts were used
for further analysis. Proteins were reduced by adding 4.5 mMDTT
for 30 min at 55 1C. Proteins were alkylated by addition of 10 mM
iodoacetamide at room temperature in the dark for 15 min. The
samples were diluted with 20 mM HEPES at pH 8.0 to achieve
a urea concentration of 4 M; then, the proteins were digested with
2 mg endoLysC (Wako, Neuss, Germany 1/250, w/w) for 4 h at room
temperature. All samples were further diluted with 20 mMHEPES
at pH 8.0 to a final urea concentration of 2 M, and the proteins
were digested with 5 mg trypsin (Promega, Leiden, Belgium)
(1/100, w/w) overnight at 37 1C. The peptides were then purified
on a SampliQ SPE C18 cartridge (Agilent, Diegem, Belgium);
from each replicate, 100 mg vacuum-dried peptides were used
for LC-MS/MS analysis (D0 vs. D6 analysis) or strong cation
exchange (SCX) fractionation (D0 vs. D8 vs. D13 analysis).
For SCX fractionation, SCX tips were made by stacking
three discs (1.5 mm diameter) of polystyrene divinylbenzene
copolymer with sulfonic acid (Emporet, 3M) in a 200 ml pipette
tip. First, the SCX tips were rinsed with 100 ml acetonitrile (ACN)
by pipetting the solvent in the tip, flicking the tip so the ACN
touched the discs, and pushing the solvent through with a
syringe. Then, each sample was dissolved in 100 ml loading
buﬀer (1% TFA in water/ACN (95 : 5, v/v)) and the peptides were
loaded on the SCX tips. After washing the tips with 50 ml loading
buﬀer, the peptides were fractionated by subsequently pipetting
up and down 20 ml of the following fractionation buﬀers:
100 mM ammonium acetate, 0.5% FA (fraction 1); 175 mM
ammonium acetate, 0.5% formic acid (FA) (fraction 2); 375 mM
ammonium acetate, 0.5% FA (fraction 3). The remaining peptides
were eluted in 2  20 ml of elution buﬀer (5% NH4OH in water/
ACN (20 : 80, v/v)) (fraction 4). To prevent deamidation in this
fraction, 2 ml 10% FA was added. The fractionated peptides were
dried by vacuum drying.
LC-MS/MS and data analysis
The peptides were dissolved in 20 ml loading solvent A (0.1%
TFA in water/ACN (98 : 2, v/v)) of which 10 ml was injected for
LC-MS/MS analysis on an Ultimate 3000 RSLCnano system
(Thermo Fisher Scientific, Ghent, Belgium) in-line connected
to a Q Exactive HF mass spectrometer (Thermo Fisher Scientific,
Ghent, Belgium) equipped with a Nanospray Flex Ion source
(Thermo Fisher Scientific, Ghent, Belgium). Trapping was per-
formed at 10 ml min1 for 4 min in trapping solvent (0.1% TFA in
water/acetonitrile (98 : 2, v/v)) on a 100 mm internal diameter
(I.D.)  20 mm trapping column (5 mm beads, C18 Reprosil-HD,
Dr Maisch, Germany) and the sample was loaded on a reverse-
phase column (made in-house, 75 mm I.D.  400 mm, 1.9 mm
beads C18 Reprosil-HD, Dr Maisch, Germany). The peptides
were eluted by a non-linear increase from 2% to 56% solvent B
(0.1% FA in water/acetonitrile (2 : 8, v/v)) over 150 min at a
constant flow rate of 250 nl min1, followed by a 10 min wash
reaching 99% solvent B and re-equilibration with solvent A
(0.1% FA in water/acetonitrile (2 : 8, v/v)). The column tempera-
ture was kept constant at 50 1C (CoControl 3.3.05, Sonation).
The mass spectrometer was operated in data-dependent mode,
automatically switching between MS and MS/MS acquisition for
the 16 most abundant ion peaks per MS spectrum. Full-scan MS
spectra (375 to 1500 m/z) were acquired at a resolution of 60000
in the Orbitrap analyzer after accumulation to a target value of
3 000000. The 16 most intense ions above a threshold value of
22000 (non-fractionated samples) or 13000 (fractionated samples)
were isolated (window of 1.5 Th) for fragmentation at a normalized
collision energy of 32% after filling the trap at a target value
of 100 000 for maximum 45 ms (non-fractionated samples) or
80 ms (fractionated samples). MS/MS spectra (200 to 2000 m/z)
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were acquired at a resolution of 15000 in the orbitrap analyser. The
S-lens RF level was set at 55, and we excluded precursor ions with
single and unassigned charge states from fragmentation selection.
Data analysis was performed with MaxQuant (version 1.5.4.1)53
using the Andromeda search engine with default search settings,
including a false discovery rate set at 1% on both the peptide and
protein level. The spectra were searched against Rattus norvegicus
proteins in the UniProt/Swiss-Prot database (database release
version of April 2015 containing 9535 rat protein sequences) as
well as the Uniprot/TrEMBL database (database release version of
April 2015 containing 27867 rat protein sequences) downloaded
from www.uniprot.org. The mass tolerances for precursor and
fragment ions were set to 4.5 and 20 ppm, respectively, during the
main search. Enzyme specificity was set as carboxy-terminal to
arginine and lysine (trypsin), also allowing cleavage at arginine/
lysine–proline bonds with a maximum of two missed cleavages.
Carbamidomethylation of cysteine residues was set as a fixed
modification and variable modifications were set to oxidation of
methionine (to sulfoxides) and acetylation of protein amino-
termini. Proteins were quantified by the MaxLFQ algorithm
integrated in the MaxQuant software.54 Only proteins with at least
one unique or razor peptide were retained for identification, while
a minimum ratio count of two unique or razor peptides was
required for quantification. Further data analysis was performed
with Perseus software (version 1.5.5.355) after loading the protein
groups file from MaxQuant. Proteins only identified by site,
reverse database hits and potential contaminants were removed,
and replicate samples were grouped. Proteins with less than three
valid values in at least one group were removed, and missing
values were imputed from a normal distribution around the
detection limit. Then, t-tests were performed (FDR = 0.01 and
S0 = 1) for pairwise comparison and to generate the volcano plots
depicted in Fig. 2A (D0 vs.D6) and Fig. 3A (D8 vs.D13). A principal
component analysis was also performed on the replicate samples
from the fractionation analysis to generate the scatter plot shown
in Fig. 3B. Furthermore, to reveal proteins whose expression levels
were strongly affected during the differentiation process in the
fractionation analysis, sample groups were defined based on
differentiation (D0 vs. D8 + D13) and differentiation time (D0 vs.
D8 vs. D13), and a two-way ANOVA test was performed to compare
the intensities of the proteins in the differentiation group with
those of the differentiation time group. For each protein, this
test calculated a p-value for differentiation and a p-value for
differentiation time. 843 proteins with a p-valueo 0.05 in at least
one of the two groups were considered to be significantly
regulated. The intensities of these proteins are shown in a heat
map in Fig. 4 after non-supervised hierarchical row clustering. The
mass spectrometry proteomics data have been deposited in the
ProteomeXchange Consortium via the PRIDE partner repository56
with the dataset identifier PXD006115.
Gene ontology and reactome analysis
For gene ontology analysis, the tool GOrilla (http://cbl-gorilla.
cs.technion.ac.il/) was employed. Therefore, a single list of
genes ranked according to the expression levels of their corres-
ponding proteins and starting with the highest expression level
in the more diﬀerentiated cell system was used and copied into
the input panel of the tool. Rattus norvegicus was chosen as
the analysis organism, and a process ontology was selected.
A p-value threshold of 105 was chosen; this is the default
choice suggested by the GOrilla tool to manage the trade-oﬀ
between comprehensiveness and conciseness. Because GOrilla
analyzes enrichment by ranking full protein lists from the most
upregulated to the most downregulated proteins, ranked input
lists were not preselected by fold change or p-value thresholds.
Other parameters were set as default.
For the Reactome analysis, the respective tool was used
(www.reactome.org). A list of genes was taken from each of
the eight clusters and inserted into the analysis window. The
genes were mapped to human pathways and exported to Excel.
Enriched pathways were ranked according to the fraction of
genes from the list that were associated with a pathway divided
by the total number of proteins in the pathway. Only pathways
associated with a minimum of 2% of the genes in the cluster
were considered.
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